PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20037296-4	2009	The frequency of concomitant use of PSK with fluoropyrimidines was 79% (56 patients).	fluoropyrimidines	45-62	TAO kinase 2	Homo sapiens	36-39	
20037296-5	2009	Among the patients who were given PSK, the frequency of concomitant use of UFT alone was higher in Stage III a patients, while the rate of concomitant use of fluoropyrimidines and Leucovorin was higher in Stage III b patients (p<0.01).	fluoropyrimidines	158-175	TAO kinase 2	Homo sapiens	34-37